Canada’s New Pharmacare Bill

NDAX Tutorial For Beginners - Watch this before you begin!

Why Turbo Busa Engines Are Perfect for Turbos

Irish lawyer's plea for Action The Hague accusing Israel of genocide

Is anyone listening...how can the world stand by and talk and have discussions while Palestinians are being slaughtered en masse...

EPIC BOAT FAILS 2023! Haulover Inlet

850HP Street Bike | 233MPH TURBO HAYABUSA

850HP Street Legal Bike | 233MPH TURBO HAYABUSA (The Fastest Street Legal Bikes on the Planet)

Pharmaceutical Companies & Money. Out of control.

How much is a human life worth? An innovative cancer therapy promises to save lives. But it is extremely expensive. Will the insurance companies pay for it? What is the manufacturer's return on investment? And do lobbyists drive up prices?

In 2018, the Kymriah gene therapy was approved in Europe. Immune cells are taken from the patient, genetically reprogrammed into cancer killer cells and returned to the patient as an infusion. The results of the Kymriah study only cover a period of 18 months. In 40 percent of patients, lymph gland cancer does not return during this time. It is not clear whether Kymriah has a long-term effect. The Swiss pharmaceutical company Novartis offers the new therapy - it costs 370,000 Swiss francs per patient. Health insurance companies are not usually prepared to pay that much and are complaining about a lack of transparency.

But the killer cells were not invented in the Novartis laboratories, but at a US university. When Professor Carl June started his research almost 30 years ago, no pharmaceutical company was interested. It was only thanks to funding from tax money and donations that he was able to develop Kymriah at all. After a story went around the world about a girl with leukemia whose cancer disappeared thanks to Kymriah, the pharmaceutical company contacted Novartis and secured exclusive marketing rights. To launch Kymriah on the market, Novartis funded the necessary clinical trials. It's not an isolated incident: Over 60% of newly approved medicines in the US are developed by small biotech companies or universities. Pharmaceutical companies today frequently act as capital providers, cooperating with universities or buying up biotech companies.

A paradigm shift has taken place in the pharmaceutical industry: Whereas high drug prices used to be justified by research costs, the industry is now using the value of gained lifetime to argue its case.

HardTalk News
Publisher HardTalk News, Blog, WebCourse
World, Local, Tyranny, Dark Pharma, Webtech, De-Google, Money, more
Email: info@hardtalknews.com | Web: hardtalknews.comPrivate Browsers: DuckDuckGo, Qwant Or SearX
Private Operating Systems: Linux or Tails
Private Cloud Servers: Skiff, Mega, pCloud, Proton, Sync, Tresorit 
Alternative to YouTube: Rumble, Odysee, Dailymotion
Dump the Sim in Your Cellphone | Webtech Shows HowCheck Out: mediahead.ca | WebCourse | RSS Feed

Trudeau Coverup | Time to Get Rid of this Prime Minister

CPC leader Pierre Poilievre holds a press conference outlining how Trudeau has been covering up the Winnipeg lab leak documents.

Inside the Most Iconic Sailing Yacht in the World!

Yacht Description: "There are very few yachts whose grace, elegance and class cut through the world of yachting to be perceived as a thing of beauty by all who see them. SHENANDOAH OF SARK is one such yacht. The very embodiment of the golden age of sail, she turns heads and wins hearts wherever she goes.

To be on board, then, is something very special indeed. With the sails set and drawing, there is an undeniable sense of exhilaration as she leans into the waves and forges gracefully on powered by nature alone. From the family-friendly, line-free guest cockpit at the heart of the action, you can watch as her talented, highly experienced crew trims and tunes the sails to extract every tenth of a knot. At anchor, her wide-open deck spaces present limitless options for relaxation, entertainment and generally being the centre of attention.

The yacht's gifted chef will serve up delicious fare from lunch on deck to beach BBQs to banquets below at the yacht's formal dining room as the saloon's baby grand piano plays. Take the tender ashore to explore delightful port towns as the sun sets or relax with a movie night on board.After another day's exceptional sailing and the sort of glamour that brought Vogue on board for a fashion shoot, you and your guests can retire to four versatile suites including a sumptuous full-beam master cabin and prepare for another day.

SHENANDOAH OF SARK combines the authenticity of a bygone era, over a century of sail, with the modern amenities that deliver the full luxury of a modern yacht charter. This is a yacht that inspires passion and she has been cherished and relentlessly maintained to deliver the ultimate sailing yacht experience every time."

Yacht Name: Shenandoah of Sark
Specs: 4 Staterooms
LOA: 54 m/178'
Beam: 8.3 m/27'
Tonage: 178 gt
Yacht's Link: https://www.burgessyachts.com/en/char...
Yacht's Website: https://syshenandoah.com
Sale Price: $10,000,000
Charter Price: $112,240 / 110,000€
Listed by: Burgess and Sandeman

How an 18th Century Sailing Battleship Works